A gp63 based vaccine candidate against Visceral Leishmaniasis

Visceral leishmaniasis is a macrophage associated disorder which leads to a profound decrease in the natural immunotherapeutic potential of the infected subjects to combat the disease. The major surface glycoprotein gp63 has been found to be a significant vaccine candidate against visceral leishmani...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Sukrat, Sundaram, Shanthy, Singh, Anand Prakash, Tripathi, Ashutosh
Formato: Texto
Lenguaje:English
Publicado: Biomedical Informatics 2011
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046035/
https://www.ncbi.nlm.nih.gov/pubmed/21383918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046035/
https://www.ncbi.nlm.nih.gov/pubmed/21383918

Ejemplares similares